This Is MS Multiple Sclerosis Knowledge & Support Community

i hope that they do a combination trial with ocrelizumab and copaxone. really, i think more combination trials with copaxone should be done, especially with a systems biology component. this should also be done with tysabri as well as with alemtuzumab. especially with alemtuzumab.